The intricate interplay between cancer stem cells and cell-of-origin of cancer: implications for therapeutic strategies

被引:4
作者
Bamodu, Oluwaseun Adebayo [1 ,2 ]
Chung, Chen-Chih [3 ,4 ,5 ]
Pisanic II, Thomas R. [6 ,7 ,8 ]
Wu, Alexander T. H. [9 ,10 ,11 ,12 ]
机构
[1] Muhimbili Univ Hlth & Allied Sci, Sch Clin Med, Directorate Postgrad Studies, Dar Es Salaam, Tanzania
[2] Ocean Rd Canc Inst, Dar Es Salaam, Tanzania
[3] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, New Taipei City, Taiwan
[4] Taipei Med Univ, Coll Med, Sch Med, Dept Neurol, Taipei, Taiwan
[5] Taipei Med Univ, Shuang Ho Hosp, Taipei Neurosci Inst, New Taipei City, Taiwan
[6] Johns Hopkins Inst NanoBioTechnol, Baltimore, MD USA
[7] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[8] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA
[9] Taipei Med Univ, Grad Inst Biomed Informat, Coll Med Sci & Technol, Program Translat Med, Taipei, Taiwan
[10] Taipei Med Univ, TMU Res Ctr Canc Translat Med, Taipei, Taiwan
[11] Taipei Med Univ Hosp, Taipei Med Univ, Clin Res Ctr, Taipei, Taiwan
[12] Grad Inst Med Sci, Natl Def Med Ctr, Taipei, Taiwan
关键词
cancer stem cells; cell-of-origin; tumorigenesis; tumor heterogeneity; cancer therapeutics; therapy resistance; personalized medicine; tumor microenvironment; EPITHELIAL-MESENCHYMAL TRANSITION; CIRCULATING TUMOR-CELLS; PROSTATE-CANCER; LUNG-CANCER; IN-VITRO; FUNCTIONAL-CHARACTERIZATION; DUAL INHIBITION; GENE-EXPRESSION; PHASE-II; HETEROGENEITY;
D O I
10.3389/fonc.2024.1404628
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Cancer stem cells (CSCs) have emerged as pivotal players in tumorigenesis, disease progression, and resistance to therapies.Objective This comprehensive review delves into the intricate relationship between CSCs and the cell-of-origin in diverse cancer types.Design Comprehensive review of thematically-relevant literature.Methods We explore the underlying molecular mechanisms that drive the conversion of normal cells into CSCs and the impact of the cell-of-origin on CSC properties, tumor initiation, and therapeutic responses. Moreover, we discuss potential therapeutic interventions targeting CSCs based on their distinct cell-of-origin characteristics.Results Accruing evidence suggest that the cell-of-origin, the cell type from which the tumor originates, plays a crucial role in determining the properties of CSCs and their contribution to tumor heterogeneity.Conclusion By providing critical insights into the complex interplay between CSCs and their cellular origins, this article aims to enhance our understanding of cancer biology and pave the way for more effective and personalized cancer treatments.
引用
收藏
页数:19
相关论文
共 213 条
[1]   High ALDH Activity Identifies Chemotherapy-Resistant Ewing's Sarcoma Stem Cells That Retain Sensitivity to EWS-FLI1 Inhibition [J].
Awad, Ola ;
Yustein, Jason T. ;
Shah, Preeti ;
Gul, Naheed ;
Katuri, Varalakshmi ;
O'Neill, Alison ;
Kong, Yali ;
Brown, Milton L. ;
Toretsky, Jeffrey A. ;
Loeb, David M. .
PLOS ONE, 2010, 5 (11)
[2]   Cancer stem cells as key drivers of tumour progression [J].
Ayob, Ain Zubaidah ;
Ramasamy, Thamil Selvee .
JOURNAL OF BIOMEDICAL SCIENCE, 2018, 25
[3]   Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay [J].
Baccelli, Irene ;
Schneeweiss, Andreas ;
Riethdorf, Sabine ;
Stenzinger, Albrecht ;
Schillert, Anja ;
Vogel, Vanessa ;
Klein, Corinna ;
Saini, Massimo ;
Baeuerle, Tobias ;
Wallwiener, Markus ;
Holland-Letz, Tim ;
Hoefner, Thomas ;
Sprick, Martin ;
Scharpff, Martina ;
Marme, Frederik ;
Sinn, Hans Peter ;
Pantel, Klaus ;
Weichert, Wilko ;
Trumpp, Andreas .
NATURE BIOTECHNOLOGY, 2013, 31 (06) :539-U143
[4]   Histone Modification in NSCLC: Molecular Mechanisms and Therapeutic Targets [J].
Bajbouj, Khuloud ;
Al-Ali, Abeer ;
Ramakrishnan, Rakhee K. ;
Saber-Ayad, Maha ;
Hamid, Qutayba .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (21)
[5]  
Bamodu OA., 2020, J Cancer Res Pract, V7, P49, DOI [10.4103/JCRP.JCRP520, DOI 10.4103/JCRP.JCRP520]
[6]   Elevated PDK1 Expression Drives PI3K/AKT/MTOR Signaling Promotes Radiation-Resistant and Dedifferentiated Phenotype of Hepatocellular Carcinoma [J].
Bamodu, Oluwaseun Adebayo ;
Chang, Hang-Lung ;
Ong, Jiann-Ruey ;
Lee, Wei-Hwa ;
Yeh, Chi-Tai ;
Tsai, Jo-Ting .
CELLS, 2020, 9 (03)
[7]   4-Acetyl-Antroquinonol B Suppresses SOD2-Enhanced Cancer Stem Cell-Like Phenotypes and Chemoresistance of Colorectal Cancer Cells by Inducing hsa-miR-324 re-Expression [J].
Bamodu, Oluwaseun Adebayo ;
Yang, Ching-Kuo ;
Cheng, Wei-Hong ;
Tzeng, David T. W. ;
Kuo, Kuang-Tai ;
Huang, Chun-Chih ;
Deng, Li ;
Hsiao, Michael ;
Lee, Wei-Hwa ;
Yeh, Chi-Tai .
CANCERS, 2018, 10 (08)
[8]   Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448 [J].
Bamodu, Oluwaseun Adebayo ;
Huang, Wen-Chien ;
Lee, Wei-Hwa ;
Wu, Alexander ;
Wang, Liang Shun ;
Hsiao, Michael ;
Yeh, Chi-Tai ;
Chao, Tsu-Yi .
BMC CANCER, 2016, 16
[9]   Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma [J].
Bar, Eli E. ;
Chaudhry, Aneeka ;
Lin, Alex ;
Fan, Xing ;
Schreck, Karisa ;
Matsui, William ;
Piccirillo, Sara ;
Vescovi, Angelo L. ;
DiMeco, Francesco ;
Olivi, Alessandro ;
Eberharta, Charles G. .
STEM CELLS, 2007, 25 (10) :2524-2533
[10]   CHK1 Inhibition Radiosensitizes Head and Neck Cancers to Paclitaxel-Based Chemoradiotherapy [J].
Barker, Holly E. ;
Patel, Radhika ;
McLaughlin, Martin ;
Schick, Ulrike ;
Zaidi, Shane ;
Nutting, Christopher M. ;
Newbold, Katie L. ;
Bhide, Shreerang ;
Harrington, Kevin J. .
MOLECULAR CANCER THERAPEUTICS, 2016, 15 (09) :2042-2054